| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/16/2005 | CN1579463A Compound cape-jasmine salted-fermented beans total extract and its preparation and use |
| 02/16/2005 | CN1579462A Ready-made traditional Chinese medicine formed from compound red-rooted salvia root effective zontent |
| 02/16/2005 | CN1579458A Danshenhong medicated liquor for treating thoracic obstruction and preparation method |
| 02/16/2005 | CN1579454A Medicine composition for treating cerebral embolism and myocardial infrarction |
| 02/16/2005 | CN1579445A Effective-component extract of Foliun-Mori and its preparation method |
| 02/16/2005 | CN1579424A Prevention of disease induced by taking high phenylalanine and treatment there for |
| 02/16/2005 | CN1579420A Veal-blood protein-removed extract infusion and its preparation process |
| 02/16/2005 | CN1579413A Meglumine adenosine cyclophosphate for injection and its preparing method |
| 02/16/2005 | CN1579410A Oral total notoginsenoside blending preparation |
| 02/16/2005 | CN1579409A Oral total notoginsenoside slow-releasing preparation |
| 02/16/2005 | CN1579399A Chuanxiongzine or chuanxiongzine salt drip pill and its preparing method |
| 02/16/2005 | CN1579389A Compound preparation for treating hypertension |
| 02/16/2005 | CN1579387A Extraction of protopine from plant, and its manufacture of medicinal preparation and use |
| 02/16/2005 | CN1579384A Ready-made medicine of traditional chinese medicine for treating ischemic cranial vascular disease |
| 02/16/2005 | CN1579383A Troxerution guttate pill and preparation method thereof |
| 02/16/2005 | CN1189482C Novel angiogenesis inhibitor |
| 02/16/2005 | CN1189479C Use of leptin in inhibition of endothelial cell proliferation |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189466C New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 02/16/2005 | CN1189214C Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 02/16/2005 | CN1189202C Compound ginkgo capsule |
| 02/16/2005 | CN1189189C Medicine for eliminating thrombus and treating apoplexy |
| 02/16/2005 | CN1189184C External use medicine for treating haemorrhoid and preparation method thereof |
| 02/16/2005 | CN1189182C Application of nano copper powder in preparation of antisenility medicine |
| 02/16/2005 | CN1189176C Astragalus root methyl-glycoside composition and preparation method |
| 02/16/2005 | CN1189174C Pharmaceutical compositions contg. cinchonine dichlorhydrate |
| 02/16/2005 | CN1189171C Hydrophilic molecular disperse solutions of carvedilol |
| 02/16/2005 | CN1189168C Use of (-)-(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2-diabetes, hyperlipidemia and hyperuricemia |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/15/2005 | US6855826 1,3-butadienes, perhydrobutadienes, ethylenes and ethanes as amino acid derivatives; hypotensive agents; antidiabetic agents and (pre)eclampsia treatments |
| 02/15/2005 | US6855818 Vasodilation; heart imaging |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855736 Molecular target of neurotoxicity |
| 02/15/2005 | US6855726 Heterocyclic amides such as 3-(1-5-((2R,6S)-2,6-dimethyltetra-hydro-1(2H)-pyridinyl)pentyl-2-oxo-1,2 -dihydro-3-quinolinyl) benzenecarboximidamide, administered as anticoagulants or for prophylaxis of cardiovascular disorders |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | US6855703 Triene steroids administered to mammals for prophylaxis of diseases and disorders such as cancer, menopause or osteoporosis |
| 02/15/2005 | US6855697 Troxerutin with a high content of trihydroxyethylrutoside and process for its preparation |
| 02/15/2005 | US6855693 Peptide for use in the treatment of cell damage caused by ischemia |
| 02/15/2005 | US6855688 ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 02/15/2005 | US6855350 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 02/15/2005 | CA2405466C Method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 02/15/2005 | CA2323720C New substances derived from aza-indolic polycyclics, processes for preparing them and pharmaceutical compounds containing them |
| 02/15/2005 | CA2123232C Pharmaceutical compositions containing ebastin or analogs thereof |
| 02/14/2005 | CA2477359A1 Pyruvate enriched onion extract |
| 02/10/2005 | WO2005012542A1 Casein hydrolyzate, process for producing the same and use thereof |
| 02/10/2005 | WO2005012355A1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 02/10/2005 | WO2005012334A1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 02/10/2005 | WO2005012293A1 Phenylazole compounds, production process, and antioxidants |
| 02/10/2005 | WO2005012272A1 Benzoxazepine compound |
| 02/10/2005 | WO2005012268A1 Sulfonamide derivative having isoxazole ring |
| 02/10/2005 | WO2005012259A1 Method of inhibiting production of osteopontin |
| 02/10/2005 | WO2005012221A1 Diphenyl ether compound, process for producing the same, and use |
| 02/10/2005 | WO2005011812A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibithors |
| 02/10/2005 | WO2005011727A1 Combination of an activator of soluble guanylate cyclase and an ace-inhibitor for the treatment of a cardiovascular or metabolic disorder |
| 02/10/2005 | WO2005011725A2 Anti-angiogenetic agent and its use, in particular in cancer treatment |
| 02/10/2005 | WO2005011703A1 2-cyano-1,3,5-triazine-4,6-diamine derivatives |
| 02/10/2005 | WO2005011693A1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 02/10/2005 | WO2005011690A1 Use of 3,7-diazabicyclo`3, 3,1 !nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients |
| 02/10/2005 | WO2005011684A1 Medicaments containing derivatives of aryl (or heteroaryl) azolylcarbinols |
| 02/10/2005 | WO2005011680A1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 02/10/2005 | WO2005011672A1 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 02/10/2005 | WO2005011670A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
| 02/10/2005 | WO2005011669A1 Medicinal composition for percutaneous administration |
| 02/10/2005 | WO2005011662A1 Adhesive patch |
| 02/10/2005 | WO2005011660A1 Use of vitamin d to down regulate the renin-angiotensin-aldosterone system |
| 02/10/2005 | WO2004080933A3 Isolation of lutein from alfalfa |
| 02/10/2005 | WO2003050295A3 Assays and implements for determining and modulating hsp90 binding activity |
| 02/10/2005 | WO2002064626A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/10/2005 | US20050033417 Coating for controlled release of a therapeutic agent |
| 02/10/2005 | US20050033414 Drug-eluting stent with multi-layer coatings |
| 02/10/2005 | US20050033261 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 02/10/2005 | US20050033066 Pkb-3564 substance with neovascularization inhibitory activity |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050033052 Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis |
| 02/10/2005 | US20050033048 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032890 Aniline-derived ligands for the thyroid receptor |
| 02/10/2005 | US20050032874 Indole derivatives |
| 02/10/2005 | US20050032866 Administering N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide or salt as antiarrhythmia agent |
| 02/10/2005 | US20050032865 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 02/10/2005 | US20050032862 Preparing a novel crystal form by sonication and temperature oscillation of a suspension; filtered and dried faster; treating cardiovascular disorders |
| 02/10/2005 | US20050032858 Novel heterocyclic compound and anti-inflamatory agent |
| 02/10/2005 | US20050032854 Administering 2-ethoxy-1-[[2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid or a salt as a hypotensive or an antidiabetic agent; impaired glucose tolerance |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032828 E. g., 4-[3-Isopropyl-3-(2-mercapto-benzothiazol-6-yl)-ureido]-piperidine-1-carboxylic acid benzyl ester; metabolic diseases; management/treatment glucose/fatty acid pathway; cardiovascular disorders; congestive heart failure; angina pectoris; antidiabetic agent, anticarcinogenic agents; obesity |
| 02/10/2005 | US20050032826 Medical devices containing rapamycin analogs |
| 02/10/2005 | US20050032825 rapamaycin derivatives used as fungicides, anticarcinogenic agents, immunosuppressants or as coatings on drug eluting stents to prevent restenosis |
| 02/10/2005 | US20050032823 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 02/10/2005 | US20050032820 Novel spiro compounds |
| 02/10/2005 | US20050032816 N-oxide anthranylamide derivatives and their use as medicaments |
| 02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
| 02/10/2005 | US20050032808 Pyrazine carboxamide compounds for use in treatment of obesity, psychiatric and neurological disorders; for example, N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |